Carbamazepine transbuccal delivery: The histo-morphological features of reconstituted human oral epithelium and buccal porcine mucosae in the transmucosal permeation

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 4, 2008, Pages 903-910

  Campisi, Giuseppina ^a   Paderni, C ^a   Saccone, R ^a   Siragusa, M G ^a   Lo Muzio, L ^b   Tripodo, C ^a   Giannola, L I ^a   Florena, A M ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Carbamazepine; Porcine buccal mucosa; Reconstituted human oral epithelium; Transbuccal drug delivery; Trigeminal neuralgia

Indexed keywords

CARBAMAZEPINE; KERATOHYALIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BUCCAL DRUG ADMINISTRATION; CELL NUCLEUS MEMBRANE; CELL STRUCTURE; CELL SWELLING; CELL VACUOLE; CHEEK MUCOSA; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG PENETRATION; HISTOLOGY; HUMAN; HUMAN CELL; MOUTH MUCOSA; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 59849084428     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100414     Document Type: Article

References (16)

1. Rossi S, Sandri G, Caramella CM. Buccal drug delivery: A challenge already won? Drug Discov Today 2005; 2:59-65.
2. Zakrzewska JM. Trigeminal neuralgia and facial pain. Semin Pain Med 2004; 2:76-84.
3. Moharamzadeh K, Brook IM, van Noort R, Scutt AM, Thornhill MH. Tissue-engineered oral mucosa: a review of the scientific literature. J Dent Res 2007; 86:115-124.
4. Bhargava S, Chapple C, Bullock A, MacNeil S. Tissue-engineered buccal mucosa - in vitro contraction and stress testing. Eur Urol 2004; 3(S): 85-94.
5. van Eyk AD, van der Bijl P. Comparative permeability of various chemical markers through human vaginal and buccal mucosa as well as porcine buccal and mouth floor mucosa. Arch Oral Biol 2004; 49:387-392.
6. Jacobsen J, van Deurs B, Pedersen M, Rassing MR. TR146 cells grown on filters as a model for huma buccal epithelium: I. Morphology, growth, barrier properties, and permeability. Int J Pharm 1995; 125: 165-184.
7. Jacobsen J, Nielsen EB, Brondum-Nielsen K, Christensen ME, Olin HB, Tommerup N, Rassing MR. Filter-grown TR146 cells as an in vitro model of human buccal epithelial permeability. Eur J Oral Sci 1999; 107:138-146.
8. Giannola LI, De Caro V, Giandalia G, Siragusa MG, Campisi G, Florena AM, Ciach T. Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features. Eur J Pharm Biopharm 2007; 65:238-246.
9. Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci 1998; 1: 15-30.
10. Franz TJ. Percutaneous absorption on the relevance of in vitro data. J Invest Dermatol 1975; 64:190-195.
11. Giannola LI, De Caro V, Giandalia G, Siragusa MG, D'Angelo M, Lo Muzio L, Campisi G. Transbuccal tablets of carbamazepine: formulation, release and absorption pattern. Int J Immunopathol Pharmacol 2005; 18:21-31.
12. Sato J, Saito T, Notani K, Fukuda H, Kaneyama K, Segami N. Diagnostic significance of carbamazepine and trigger zones in trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radiol Ended 2004; 97:18-22.
13. Cheshire WP. Trigeminal neuralgia: for one nerve a multitude of treatments. Expert Rev Neurother 2007; 7:1565-1579.
14. Rozen TD. Antiepileptic drugs in the management of cluster headache and trigeminal neuralgia. Headache 2001; 41:25-32.
15. Wiffen PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev 2005; 20:CD005451.
16. McEvoy GK. The Board of the American Health-System Pharmacists. In AHFS Drug Information. Bethesda, MD, 2005.